Petros Pharmaceuticals, Inc. Gain (Loss) Related to Litigation Settlement
Petros Pharmaceuticals, Inc. (PTPI) reported Gain (Loss) Related to Litigation Settlement of $3.39 million for the 12-month period ending 2022-12-31, per its 10-K filed 2024-04-01.
Discontinued › Income Statement › Other Income
us-gaap:GainLossRelatedToLitigationSettlement · last filed 2024-04-01
- Petros Pharmaceuticals, Inc. gain (loss) related to litigation settlement for the quarter ending 2022-12-31 was $0.00.
- Petros Pharmaceuticals, Inc. gain (loss) related to litigation settlement for the quarter ending 2022-09-30 was $0.00.
- Petros Pharmaceuticals, Inc. gain (loss) related to litigation settlement for the quarter ending 2022-06-30 was $0.00.
- Petros Pharmaceuticals, Inc. gain (loss) related to litigation settlement for the quarter ending 2022-03-31 was $3.39M.
- Petros Pharmaceuticals, Inc. gain (loss) related to litigation settlement for fiscal 2022 was $3.39M.
| Period end | Gain (Loss) Related to Litigation Settlement 3 month | Gain (Loss) Related to Litigation Settlement 6 month | Gain (Loss) Related to Litigation Settlement 9 month | Gain (Loss) Related to Litigation Settlement 12 month |
|---|---|---|---|---|
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $0.00 derived: sum of 2 quarters · filed 2024-04-01 | $0.00 derived: sum of 3 quarters · filed 2024-04-01 | $3.39M 10-K · filed 2024-04-01 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-15 | $0.00 derived: sum of 2 quarters · filed 2023-11-15 | $3.39M 10-Q · filed 2023-11-15 | |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $3.39M 10-Q · filed 2023-08-14 | ||
| 2022-03-31 | $3.39M 10-Q · filed 2023-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B |